BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16885338)

  • 21. Comprehensive protein tyrosine phosphatase mRNA profiling identifies new regulators in the progression of glioma.
    Bourgonje AM; Verrijp K; Schepens JT; Navis AC; Piepers JA; Palmen CB; van den Eijnden M; Hooft van Huijsduijnen R; Wesseling P; Leenders WP; Hendriks WJ
    Acta Neuropathol Commun; 2016 Sep; 4(1):96. PubMed ID: 27586084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pten signaling in gliomas.
    Knobbe CB; Merlo A; Reifenberger G
    Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhood.
    Bredel M; Pollack IF; Hamilton RL; James CD
    Clin Cancer Res; 1999 Jul; 5(7):1786-92. PubMed ID: 10430083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symbiotic Macrophage-Glioma Cell Interactions Reveal Synthetic Lethality in PTEN-Null Glioma.
    Chen P; Zhao D; Li J; Liang X; Li J; Chang A; Henry VK; Lan Z; Spring DJ; Rao G; Wang YA; DePinho RA
    Cancer Cell; 2019 Jun; 35(6):868-884.e6. PubMed ID: 31185211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MAb 806 enhances the efficacy of ionizing radiation in glioma xenografts expressing the de2-7 epidermal growth factor receptor.
    Johns TG; McKay MJ; Cvrljevic AN; Gan HK; Taylor C; Xu H; Smyth FE; Scott AM
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):572-8. PubMed ID: 20638193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines.
    Bax DA; Gaspar N; Little SE; Marshall L; Perryman L; Regairaz M; Viana-Pereira M; Vuononvirta R; Sharp SY; Reis-Filho JS; Stávale JN; Al-Sarraj S; Reis RM; Vassal G; Pearson AD; Hargrave D; Ellison DW; Workman P; Jones C
    Clin Cancer Res; 2009 Sep; 15(18):5753-61. PubMed ID: 19737945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localization of aberrant messenger RNA of epidermal growth factor receptor (EGFR) in malignant glioma.
    Tsugu A; Kijima H; Yamazaki H; Ohnishi Y; Takamiya Y; Abe Y; Ueyama Y; Sato O; Tamaoki N; Nakamura M
    Anticancer Res; 1997; 17(3C):2225-32. PubMed ID: 9216693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of the type III epidermal growth factor receptor variant mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivity.
    Lammering G; Hewit TH; Holmes M; Valerie K; Hawkins W; Lin PS; Mikkelsen RB; Schmidt-Ullrich RK
    Clin Cancer Res; 2004 Oct; 10(19):6732-43. PubMed ID: 15475464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators.
    Lo HW; Cao X; Zhu H; Ali-Osman F
    Clin Cancer Res; 2008 Oct; 14(19):6042-54. PubMed ID: 18829483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib.
    Haas-Kogan DA; Prados MD; Tihan T; Eberhard DA; Jelluma N; Arvold ND; Baumber R; Lamborn KR; Kapadia A; Malec M; Berger MS; Stokoe D
    J Natl Cancer Inst; 2005 Jun; 97(12):880-7. PubMed ID: 15956649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of chromosomal imbalances by comparative genomic hybridization and expression of EGFR, PTEN, p53, and MIB-1 in diffuse gliomas.
    Yakut T; Gutenberg A; Bekar A; Egeli U; Gunawan B; Ercan I; Tolunay S; Doygun M; Schulten HJ
    Oncol Rep; 2007 May; 17(5):1037-43. PubMed ID: 17390041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas.
    Liu W; James CD; Frederick L; Alderete BE; Jenkins RB
    Cancer Res; 1997 Dec; 57(23):5254-7. PubMed ID: 9393744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTEN gene transfer suppresses the invasive potential of human malignant gliomas by regulating cell invasion-related molecules.
    Furukawa K; Kumon Y; Harada H; Kohno S; Nagato S; Teraoka M; Fujiwara S; Nakagawa K; Hamada K; Ohnishi T
    Int J Oncol; 2006 Jul; 29(1):73-81. PubMed ID: 16773187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation-Induced DNA Damage Cooperates with Heterozygosity of TP53 and PTEN to Generate High-Grade Gliomas.
    Todorova PK; Fletcher-Sananikone E; Mukherjee B; Kollipara R; Vemireddy V; Xie XJ; Guida PM; Story MD; Hatanpaa K; Habib AA; Kittler R; Bachoo R; Hromas R; Floyd JR; Burma S
    Cancer Res; 2019 Jul; 79(14):3749-3761. PubMed ID: 31088835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways.
    Park CM; Park MJ; Kwak HJ; Lee HC; Kim MS; Lee SH; Park IC; Rhee CH; Hong SI
    Cancer Res; 2006 Sep; 66(17):8511-9. PubMed ID: 16951163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A dual phosphoinositide-3-kinase alpha/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma.
    Fan QW; Cheng CK; Nicolaides TP; Hackett CS; Knight ZA; Shokat KM; Weiss WA
    Cancer Res; 2007 Sep; 67(17):7960-5. PubMed ID: 17804702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas.
    Thorarinsdottir HK; Santi M; McCarter R; Rushing EJ; Cornelison R; Jales A; MacDonald TJ
    Clin Cancer Res; 2008 Jun; 14(11):3386-94. PubMed ID: 18519768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of epidermal growth factor receptor amplification in malignant gliomas.
    Sauter G; Maeda T; Waldman FM; Davis RL; Feuerstein BG
    Am J Pathol; 1996 Apr; 148(4):1047-53. PubMed ID: 8644846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of collapsin response mediator Protein1, as detected by iTRAQ analysis, promotes invasion of human gliomas expressing mutant EGFRvIII.
    Mukherjee J; DeSouza LV; Micallef J; Karim Z; Croul S; Siu KW; Guha A
    Cancer Res; 2009 Nov; 69(22):8545-54. PubMed ID: 19903856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effective silencing of EGFR with RNAi demonstrates non-EGFR dependent proliferation of glioma cells.
    Vollmann A; Vornlocher HP; Stempfl T; Brockhoff G; Apfel R; Bogdahn U
    Int J Oncol; 2006 Jun; 28(6):1531-42. PubMed ID: 16685454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.